Delivery Order SPE2DB22D3016-SPE2DB24FAXA3
Award Date
5/30/24
Potential Completion Date
5/31/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML pharmaceutical products. The $2,140.52 order has a completion date of February 27, 2024 and was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as Amerisourcebergen's primary contract vehicle to deliver...
The U.S. Defense Logistics Agency (DLA) awarded a $2,052.90 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 25 mcg/0.5 mL TYPHIM VI syringes by May 1, 2024. This award is under Amerisourcebergen's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,421.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a potential value of up to $999,999,999.00 and runs through December 31, 2025. The IDC serves as the primary contract...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,021,744 units of the pharmaceutical product TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract, valued at $11,809.01, has a period of performance through March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger $999,999,999.00 indefinite delivery contract...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,181,393 units of the pharmaceutical product TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The $5,617.86 contract has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $27,368.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML pharmaceuticals. This delivery order falls under an indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract has a ceiling value of $62,156.88 and a period of performance through March 4, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,545,937 units of the pharmaceutical product TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML. The contract has a total potential value of $5,276.45 and a completion date of February 6, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor to deliver this...
The U.S. Defense Logistics Agency (DLA) awarded a $4,321.79 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of 4565422133 TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The award has an ultimate completion date of August 13, 2024. This order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML pharmaceuticals. The contract has a completion date of February 5, 2024 and a potential value of $3,586.12. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order, which was not set aside for any particular business type. This order is part...